Related Experiment Videos
Cytoferrin, maternofetal iron transport, and neonatal hemochromatosis
A S Knisely1, R W Grady, E E Kramer
1Department of Pathology, New York Hospital-Cornell Medical Center, New York.
Insights
Cytoferrin, an iron-binding compound, is highly concentrated in infants with neonatal hemochromatosis. This suggests cytoferrin plays a role in iron transport between mother and fetus.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Maternal-Fetal Medicine
Background:
- Neonatal hemochromatosis is a severe iron overload disorder in newborns.
- The precise mechanisms of maternofetal iron transport are not fully elucidated.
- Cytoferrin is a low-molecular-weight iron-binding compound found in serum.
Observation:
- Serum cytoferrin concentrations were markedly elevated (270x) in an infant with neonatal hemochromatosis compared to normal adults.
- Cord sera from normal neonates showed lower, but still elevated (2x), cytoferrin levels compared to adults.
- Maternal serum cytoferrin levels were not elevated, while placental tissue concentrations were comparable to other mammalian tissues.
Findings:
- A significant transplacental gradient in serum cytoferrin concentrations was observed.
- These findings suggest cytoferrin may be involved in maternofetal iron transport.
- Cytoferrin might participate in iron transport pathways beyond transferrin.
Implications:
- Further research into cytoferrin's role in neonatal hemochromatosis is warranted.
- Understanding cytoferrin's function could reveal new insights into iron metabolism disorders.
- This study highlights a potential novel pathway for iron transport during pregnancy.
Abstract:
The serum concentration of cytoferrin, a low-molecular-weight iron-binding compound, in an infant with neonatal hemochromatosis was significantly elevated (270X) by comparison with normal adult values. Concentrations of cytoferrin in cord sera from 25 normal term neonates were substantially lower but also were elevated (2X) by comparison with normal adult values. Concentrations of cytoferrin in placental tissues were comparable to values previously obtained for various mammalian tissues, and concentrations of cytoferrin in maternal sera were not elevated. This transplacental gradient in serum concentrations of cytoferrin suggests that cytoferrin may be involved in maternofetal iron transport. Although iron is known to be taken up by the hemochorial placenta via trophoblast brush border receptors for transferrin, further iron handling within the placenta is poorly understood. In particular, the routes or carriers by which iron enters the fetal circulation have not been identified. Cytoferrin may participate in stages of maternofetal iron transport distal to transferrin, and further investigation of the role of cytoferrin in neonatal hemochromatosis and other disorders may be warranted.